{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:59:37Z","timestamp":1773057577070,"version":"3.50.1"},"reference-count":37,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Background: Postpartum cardiomyopathy (PPCM) is a rare but life-threatening condition characterized by left ventricular dysfunction occurring in the peripartum period. Alterations in carnitine metabolism have been implicated in myocardial energy dysregulation, yet targeted metabolic profiling in PPCM remains limited. Methods: We conducted a targeted metabolomics study comparing serum carnitine and acylcarnitine profiles between 40 PPCM patients and 40 age-matched healthy controls. Samples were analyzed using LC\u2013MS\/MS. Multivariate analyses (PCA and PLS-DA), univariate statistics (t-test, ANOVA, and Tukey\u2019s HSD), and ROC curve analysis were applied to identify discriminatory metabolites and their diagnostic potential. Results: PPCM patients showed significantly decreased free carnitine (C0, p &lt; 0.001) and elevated short-chain acylcarnitines such as acetylcarnitine (C2, p &lt; 0.001) and propionylcarnitine (C3, p &lt; 0.001) compared to controls. Notably, C14:1 and C18:1 were significantly reduced, whereas C6DC was elevated in PPCM (p &lt; 0.001). PLS-DA and VIP analyses highlighted C2, C6DC, and C16 as key discriminators between groups. ROC analysis confirmed limited but notable diagnostic performance for C2 (AUC = 0.633), C6DC (AUC = 0.635), and C16 (AUC = 0.623). Conclusions: Our findings demonstrate that PPCM is associated with profound alterations in carnitine metabolism, particularly reductions in long-chain acylcarnitines and increases in short-chain species. Specific metabolites such as C2, C6DC, and C16 may serve as potential biomarker candidates for PPCM diagnosis and prognosis. These results highlight the utility of targeted metabolomics in uncovering novel metabolic signatures of cardiomyopathy.<\/jats:p>","DOI":"10.3390\/metabo16030180","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:58:45Z","timestamp":1773046725000},"page":"180","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted Metabolomic Profiling of Carnitines Reveals Diagnostic Candidates in Postpartum Cardiomyopathy"],"prefix":"10.3390","volume":"16","author":[{"given":"Yasemin Behram","family":"Kandemir","sequence":"first","affiliation":[{"name":"Department of Anatomy, Faculty of Medicine, \u0130stanbul Ayd\u0131n University, 34295 \u0130stanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130smail","family":"Koyuncu","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Harran University, 63200 \u015eanl\u0131urfa, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veysel","family":"Tosun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mehmet Akif \u0130nan Training and Research Hospital, 63200 \u015eanl\u0131urfa, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00dcnal","family":"G\u00fcntekin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Akdeniz University, 07100 Antalya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: A position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy","volume":"12","author":"Sliwa","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ejhf.1493","article-title":"Pathophysiology, diagnosis and management of peripartum cardiomyopathy: A position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"21","author":"Bauersachs","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10741-024-10435-5","article-title":"Peripartum cardiomyopathy: A comprehensive and contemporary review","volume":"29","author":"Sigauke","year":"2024","journal-title":"Heart Fail. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/ejhf.882","article-title":"Peripartum cardiomyopathy in Denmark: A retrospective, population-based study of incidence, management and outcome","volume":"19","author":"Johansen","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2020.01.057","article-title":"Promoting awareness of peripartum cardiomyopathy (PPCM)","volume":"305","author":"Fett","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/jnc.15124","article-title":"Glioma cells survival depends both on fatty acid oxidation and on functional carnitine transport by SLC22A5","volume":"156","author":"Juraszek","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrendo.2015.129","article-title":"Acylcarnitines\u2014Old actors auditioning for new roles in metabolic physiology","volume":"11","author":"McCoin","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","article-title":"Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: Diagnostic and prognostic value of metabolomics","volume":"65","author":"Cheng","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure: Implications beyond ATP production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ. Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kandemir, Y.B., G\u00fcntekin, \u00dc., Tosun, V., Koyuncu, \u0130., and Y\u00fcksekda\u011f, \u00d6. (2025). Altered carnitine metabolism in ischemic and non-ischemic cardiomyopathy: A comparative metabolomics study using LC-MS\/MS. Metabolites, 15.","DOI":"10.3390\/metabo15110685"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2013.05.009","article-title":"Toward new biomarkers of cardiometabolic diseases","volume":"18","author":"Roberts","year":"2013","journal-title":"Cell Metab."},{"key":"ref_13","first-page":"7411","article-title":"Amino acid profiling to predict prognosis in patients with heart failure","volume":"11","author":"Hiraiwa","year":"2022","journal-title":"J. Clin. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zordoky, B.N., Sung, M.M., Ezekowitz, J., Mandal, R., Han, B., Bjorndahl, T.C., Bouatra, S., Anderson, T., Oudit, G.Y., and Wishart, D.S. (2015). Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124844"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2014An engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Weigert, C., and Liu, X. (2023). State-of-the-Art Metabolomics and Lipidomics in Life Sciences: Methods and Applications, MDPI.","DOI":"10.3390\/books978-3-7258-0104-6"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2015.10.079","article-title":"Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility with Mechanical Circulatory Support","volume":"67","author":"Ahmad","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11306-021-01805-3","article-title":"Serum metabolic fingerprinting of psoriasis and psoriatic arthritis patients using solid-phase microextraction\u2014Liquid chromatography\u2014High-resolution mass spectrometry","volume":"17","author":"Looby","year":"2021","journal-title":"Metabolomics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","article-title":"Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance","volume":"7","author":"Koves","year":"2008","journal-title":"Cell Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","article-title":"Carnitine transport and fatty acid oxidation","volume":"1863","author":"Longo","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Cell Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1002\/ehf2.14449","article-title":"Increased acylcarnitines in infant heart failure indicate fatty acid oxidation inhibition: Towards therapeutic options?","volume":"10","author":"Issa","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"H768","DOI":"10.1152\/ajpheart.00820.2016","article-title":"Circulating acylcarnitine profile in human heart failure: A surrogate of fatty acid metabolic dysregulation in mitochondria and beyond","volume":"313","author":"Ruiz","year":"2017","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_23","first-page":"1234","article-title":"Medium-chain dicarboxylic acylcarnitines increase with elevated \u03c9-oxidation in models of impaired fatty acid \u03b2-oxidation","volume":"56","author":"Fiamoncini","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11040","article-title":"Cardiac angiogenic imbalance leads to peripartum cardiomyopathy","volume":"485","author":"Patten","year":"2012","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy","volume":"128","author":"Kaminski","year":"2007","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jacc.2007.09.055","article-title":"Combined Metabolomic and Proteomic Analysis of Human Atrial Fibrillation","volume":"51","author":"Mayr","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11897-016-0289-5","article-title":"Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights from Metabolomic Profiling","volume":"13","author":"Hunter","year":"2016","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ejheart.2008.07.005","article-title":"Reversal of IFN-\u03b3, oxLDL and NT-proBNP Serum Levels Correlate with Clinical Improvement in Patients with Peripartum Cardiomyopathy","volume":"10","author":"Forster","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1093\/eurheartj\/ehu050","article-title":"Titin Gene Mutations Are Common in Families with Both Peripartum Cardiomyopathy and Dilated Cardiomyopathy","volume":"35","author":"Posafalvi","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrcardio.2014.37","article-title":"Pathophysiology and epidemiology of peripartum cardiomyopathy","volume":"11","author":"Sliwa","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0735-1097(02)01967-8","article-title":"Altered Myocardial Fatty Acid and Glucose Metabolism in Idiopathic Dilated Cardiomyopathy","volume":"40","author":"Vedala","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9491615","DOI":"10.1155\/2021\/9491615","article-title":"Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials","volume":"2021","author":"Weng","year":"2021","journal-title":"BioMed Res. Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6274854","DOI":"10.1155\/2017\/6274854","article-title":"Efficacy and Safety of L-Carnitine Treatment for Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials","volume":"2017","author":"Song","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000318810","article-title":"L-carnitine treatment in patients with mild diastolic heart failure is associated with improvement in diastolic function and symptoms","volume":"116","author":"Serati","year":"2010","journal-title":"Cardiology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/00129784-200101030-00005","article-title":"Systematic Review of the Efficacy and Safety of Perhexiline in the Treatment of Ischemic Heart Disease","volume":"1","author":"Killalea","year":"2001","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jacc.2006.03.060","article-title":"A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure","volume":"48","author":"Fragasso","year":"2006","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/3\/180\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:27:15Z","timestamp":1773048435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/3\/180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["metabo16030180"],"URL":"https:\/\/doi.org\/10.3390\/metabo16030180","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}